Status:
COMPLETED
Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipaemia
Atherosclerosis Risk
Eligibility:
All Genders
35-74 years
Brief Summary
The present project is aimed at determining the prevalence of LDL-C \<130 mg/dl with hsCRP ≥2mg/l, and of HDL-C \< 40 mg/dl in Spain together with the estimation of cardiovascular risk, to analyze the...
Eligibility Criteria
Inclusion
- Have an Informed consent form signed when the patient accepted to participate in the study already performed.
- Spanish population between
- Data from Epidemiological studies performed after the year 2000
Exclusion
- Spanish population outside the age range
- Data from Epidemiological studies performed before the year 2000
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
30181 Patients enrolled
Trial Details
Trial ID
NCT00998062
Start Date
November 1 2009
End Date
October 1 2011
Last Update
October 20 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Andalucia, Andalusia, Spain
2
Research Site
Canarias, Canary Islands, Spain
3
Research Site
Castilla Y Leon, Castille and León, Spain
4
Research Site
Talavero, Castille-La Mancha, Spain